Search Result

Results for "

Thr

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Ser/Thr Kinase (4) Ser/Thr Protease (9) Thyroid Hormone Receptor (31) 15-PGDH (1) 5-HT Receptor (2) Acetyl-CoA Carboxylase (1) ADAMTS (2) Adenylate Cyclase (4) Adhesion G Protein-coupled Receptors (AGPCRs) (2) Adrenergic Receptor (2) Akt (19) Amino Acid Decarboxylase (2) Amino Acid Derivatives (50) AMPK (5) Amylases (1) Amylin Receptor (30) Amyloid-β (15) Angiotensin Receptor (7) Angiotensin-converting Enzyme (ACE) (8) Annexin A (4) Antibiotic (29) Antifolate (2) AP-1 (2) APC (1) Apelin Receptor (APJ) (4) Apoptosis (71) Aquaporin (4) Arenavirus (3) Arp2/3 Complex (1) Arrestin (3) Aurora Kinase (1) Autophagy (17) Bacterial (180) Bcl-2 Family (11) BCL6 (2) Beta-secretase (1) Biochemical Assay Reagents (49) Bombesin Receptor (4) Bradykinin Receptor (1) c-Met/HGFR (1) c-Myc (1) Cadherin (2) Calcium Channel (36) Calmodulin (6) CaMK (11) Carboxypeptidase (1) Casein Kinase (4) Caspase (16) CaSR (2) Cathepsin (5) CCR (4) CD3 (1) CD38 (1) CD47 (2) CD74 (1) CDK (8) CFTR (2) CGRP Receptor (30) Checkpoint Kinase (Chk) (1) CHIKV (1) Chloride Channel (3) Cholecystokinin Receptor (4) Cholinesterase (ChE) (3) CMV (6) Collagen (4) Complement System (7) CRFR (23) CXCR (10) Cyclic GMP-AMP Synthase (1) Cytochrome P450 (3) Dengue Virus (3) Deubiquitinase (2) Dipeptidyl Peptidase (1) DNA/RNA Synthesis (4) Dopamine Receptor (2) Drug Derivative (13) Drug Intermediate (3) Drug Isomer (2) Drug Metabolite (1) DYRK (1) EBV (5) EGFR (18) Elastase (3) ELOVL (1) Endogenous Metabolite (31) Endothelin Receptor (7) Enterovirus (4) Ephrin Receptor (1) Epigenetic Reader Domain (1) ERK (16) Estrogen Receptor/ERR (3) Factor Xa (1) FAK (3) FAP (3) Ferroportin (1) Ferroptosis (3) FGFR (2) Fluorescent Dye (18) Formyl Peptide Receptor (FPR) (3) Fungal (22) FXR (2) G protein-coupled Bile Acid Receptor 1 (1) G Protein-coupled Receptor Kinase (GRK) (2) GABA Receptor (7) Galectin (1) Gap Junction Protein (3) GCGR (77) GHSR (14) GLP Receptor (59) Glucocorticoid Receptor (1) Glucose-6-Phosphate Isomerase (GPI) (1) Glutathione Peroxidase (1) Glycoprotein VI (1) GnRH Receptor (6) GSK-3 (5) Guanylate Cyclase (9) HBV (2) HCV (3) HCV Protease (1) HDAC (2) Hedgehog (1) Hexokinase (1) HIF/HIF Prolyl-Hydroxylase (1) Histone Demethylase (3) Histone Methyltransferase (4) HIV (31) HIV Protease (1) HPV (8) HSP (5) HSV (2) IFNAR (4) IGF-1R (4) iGluR (8) IKK (3) Indoleamine 2,3-Dioxygenase (IDO) (1) Influenza Virus (17) Insulin Receptor (49) Integrin (22) Interleukin Related (27) IPK Superfamily (2) Isotope-Labeled Compounds (43) JNK (17) Kallikrein (2) Keap1-Nrf2 (6) Kisspeptin Receptor (3) LAG-3 (2) LDLR (6) Ligands for Target Protein for PROTAC (1) Lipocalin Family (1) Liposome (1) Lipoxygenase (1) LRRK2 (1) mAChR (3) MAPKAPK2 (MK2) (1) MARCKS (3) MCHR1 (GPR24) (2) MDM-2/p53 (15) MEK (5) Melanocortin Receptor (6) mGluR (2) MHC (9) Mitochondrial Metabolism (3) Mitophagy (1) MMP (7) Motilin Receptor (6) mTOR (1) Mucin (2) MyD88 (2) Myosin (3) nAChR (7) NADPH Oxidase (2) Natriuretic Peptide Receptor (NPR) (4) Neurokinin Receptor (9) Neuromedin U Receptor (NMUR) (1) Neuropeptide B/W Receptor (4) Neuropeptide FF Receptor (5) Neuropeptide S Receptor (2) Neuropeptide Y Receptor (68) NF-κB (13) NO Synthase (6) NOD-like Receptor (NLR) (2) Nuclear Factor of activated T Cells (NFAT) (1) Nuclear Hormone Receptor 4A/NR4A (3) Nucleoside Antimetabolite/Analog (1) OGA (1) Opioid Receptor (28) Orexin Receptor (OX Receptor) (13) Orphan Receptor (1) Oxytocin Receptor (5) P-glycoprotein (1) P2X Receptor (2) p38 MAPK (17) PACAP Receptor (20) PAK (1) Parasite (10) PARP (1) PCSK9 (4) PD-1/PD-L1 (11) PDK-1 (1) Penicillin-binding protein (PBP) (1) Peptide-Drug Conjugates (PDCs) (5) PERK (1) PGC-1α (1) Phosphatase (3) Phosphodiesterase (PDE) (4) Phospholipase (2) Phosphomannose Isomerase (PMI) (1) Phytohormone (1) PI3K (7) PKA (10) PKC (22) PKG (1) Polo-like Kinase (PLK) (2) Potassium Channel (62) Prion Protein (1) Prostaglandin Receptor (1) PROTACs (3) Protease Activated Receptor (PAR) (7) Proteasome (6) Protein Arginine Deiminase (1) Proton Pump (4) PSMA (2) PTHR (9) RABV (5) RAD51 (1) Radionuclide-Drug Conjugates (RDCs) (17) Raf (5) Ras (12) Reactive Oxygen Species (ROS) (14) Reference Standards (2) Renin (1) Ribosomal S6 Kinase (RSK) (1) RIP kinase (1) ROCK (1) ROS Kinase (1) RSV (1) RXFP Receptor (4) SARS-CoV (9) Secretin Receptor (9) Sex Pheromone (1) Sirtuin (1) Small Interfering RNA (siRNA) (1) Sodium Channel (62) Somatostatin Receptor (36) SOS1 (2) Src (3) STAT (18) Tau Protein (9) Telomerase (1) TET Protein (2) TGF-beta/Smad (8) TGF-β Receptor (1) Thrombin (4) TMV (1) TNF Receptor (8) Toll-like Receptor (TLR) (6) Transferrin Receptor (2) Transmembrane Glycoprotein (13) TREM receptor (1) Trk Receptor (1) TRP Channel (4) Tyrosinase (1) ULK (1) Urotensin Receptor (4) Vasopressin Receptor (5) VEGFR (11) Virus Protease (3) VSV (1) WNK Kinase (1) Wnt (6) YAP (4) α-synuclein (13) β-catenin (6)
By Research Areas:	Cancer (398) Cardiovascular Disease (166) Endocrinology (114) Infection (271) Inflammation/Immunology (299) Metabolic Disease (342) Neurological Disease (427)
Click Chemistry:	Alkynes (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) siRNAs (1)

1806

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

2018

Peptides

MCE Kits

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Targets Recommended: Ser/Thr Kinase Ser/Thr Protease Thyroid Hormone Receptor

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-147055

THR-β agonist 5	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 5 (compound 54) is a potent *THR-β* agonist, with an EC₅₀ of <50 nM .

HY-P3467

*(Thr4,Gly7)-Oxytocin* 2 Publications Verification	Oxytocin Receptor Potassium Channel	Neurological Disease
(Thr4,Gly7)-Oxytocin, an Oxytocin analogue, is a specific OT receptor agonist. (Thr4,Gly7)-Oxytocin also excites subicular neurons via activation of TRPV1 channels, and depression of K ⁺ channels. .

HY-124890

Thr101	Phosphomannose Isomerase (PMI) Glucose-6-Phosphate Isomerase (GPI)	Metabolic Disease
Thr101 is an inhibitor (IC₅₀=2.9 μM) of phosphomannose isomerase (PMI).PMI can compete with phosphomannose mutase 2 (PMM2) for the binding site of Man-6-P and convert mannose-6-phosphate (Man-6-P) into fructose-6-phosphate (Fru-6-P) .Thr101 only specifically inhibits PMI and not PMM2. Thr101 can be used for research of congenital disorder of glycosylation type Ia (CDG-Ia) .

HY-P991429

THR-317	VEGFR	Metabolic Disease
THR-317 is a human monoclonal antibody (mAb) targeting PLGF. THR-317 can be used in Diabetic retinopathy research .

HY-P11354

THR-123	TGF-β Receptor Apoptosis Interleukin Related Integrin Cadherin	Inflammation/Immunology
THR-123 is an orally active ALK3 peptide agonist. THR-123 has a relatively weak binding to ALK2, but does not bind to ALK6. THR-123 suppresses inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reverses established fibrosis in five mouse models of acute and chronic renal injury. THR-123 can be used for the study of kidney fibrosis .

HY-P4699

*(Thr17)-c-Jun (11-23)*	JNK	Others
(Thr17)-c-Jun (11-23) is a fragment peptide of c-Jun.

HY-160266

THR-β agonist 7	Thyroid Hormone Receptor	Metabolic Disease Cancer
THR-β agonist-1 (Example 2) is a *THR-β* agonist, with EC₅₀ values of 52 nM and 1017 nM for THR-β and THR-α, respectively .

HY-160416

THR-β modulator-2	Thyroid Hormone Receptor	Endocrinology
THR-β modulator-2 (compound 40) is a thyroid hormone receptor β (THR-β) modulator .

HY-149218

THR-β agonist 6	Thyroid Hormone Receptor	Metabolic Disease Inflammation/Immunology
THR-β agonist 6 is an orally active, selective thyroid hormone receptor β (THR-β) agonist with EC₅₀s of 0.03 μM and 0.22 μM for THR-β and THR-α, respectively. THR-β agonist 6 exhibits an xcellent liver-to-serum ratio of 93:1 in mice. THR-β agonist 6 has the potential for nonalcoholic steatohepatitis (NASH) research .

HY-153637

THR-β modulator-1	Thyroid Hormone Receptor	Endocrinology
THR-β modulator-1 (compound 1a) is a potent thyroid hormone receptor β modulator. THR-β modulator-1 can be used in research of thyroid hormone receptor related disorders .

HY-175676

THR-β agonist 10	Thyroid Hormone Receptor	Metabolic Disease Inflammation/Immunology
THR-β agonist 10 is an orally active and selective *THR-β* agonist, with an EC₅₀ of 11 nM. THR-β agonist 10 significantly reduces ALT (Alanine Aminotransferase), TC (Total Cholesterol), and LDL-C (Low-Density Lipoprotein Cholesterol) levels, and improves steatosis, ballooning, inflammation and fibrosis in the metabolic dysfunction-associated steatohepatitis (MASH) mouse model. THR-β agonist 10 can be used for the study of MASH .

HY-143613A

THR-β agonist 2 diacetate	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 2 diacetate (Compound 3) is a potent agonist of *THR-β. THR*-β agonist 2 diacetate has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases .

HY-178015

THR-β agonist 11	Thyroid Hormone Receptor	Metabolic Disease Inflammation/Immunology
THR-β agonist 11 is an orally active and selective thyroid hormone receptor (THR-β) agonist. THR-β agonist 11 shows potent cholesterol-lowering activity in cholesterol-fed rats. THR-β agonist 11 significantly reduces serum total TG, LDL-cholesterol, liver total TC and TG levels, and alleviates hepatic steatosis, inflammation and fibrosis in HFD-CCl4-induced Metabolic dysfunction-associated steatohepatitis (MASH) model mice. THR-β agonist 11 can be used for the study of metabolic dysfunction-associated steatohepatitis (MASH) and other fibrotic diseases .

HY-143614

THR-β agonist 3	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 3 is a potent agonist of *THR-β. THR*-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6) .

HY-143613

THR-β agonist 2	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 2 is a potent agonist of *THR-β. THR*-β agonist 2 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021121210A1, compound 3) .

HY-142917

THR-β agonist 4	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 4 is a potent agonist of *THR-β. THR*-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72) .

HY-171013

THR-β agonist 8	Thyroid Hormone Receptor	Neurological Disease Metabolic Disease
THR-β agonist 8 (Compound 1) is an orally active agonist of TRα and TRβ. THR-β agonist 8 is promising for research of thyroid hormone-related diseases .

HY-174887

THR-β agonist 9	Thyroid Hormone Receptor AMPK Acetyl-CoA Carboxylase Mitochondrial Metabolism	Metabolic Disease
THR-β agonist 9 is a potent, selective, and His435 mutation-sensitive *THR-β* (EC₅₀: 3.2 nM) agonist. THR-β agonist 9 has moderate selectivity (approximately 10-fold) and good activation capacity (EC₅₀: 134.2 nM to 515.5 nM) for multiple His435 mutants (H435A, H435Y, and H435R). THR-β agonist 9 has the potential to be used in the study of dyslipidemia, metabolic dysfunction-associated steatohepatitis (MASH), or resistance to thyroid hormone (RTH) .

HY-142441

THR-β agonist 1	Thyroid Hormone Receptor	Endocrinology
THR-β Agonist 1 is a potent and selective agonist of THRβ. Thyroid hormone receptor mediates the physiological activity of thyroid hormones which plays a key role in normal growth and development of the body and in maintaining metabolic balance. THR-β Agonist 1 has the potential for the research of thyroid hormone receptor-related diseases (extracted from patent WO2021104288A1, compound 2) .

HY-P5309

*(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide*	Biochemical Assay Reagents	Inflammation/Immunology
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .

HY-P5309A

*(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide TFA*	Biochemical Assay Reagents	Inflammation/Immunology
(Thr(GalNAc)4,7,15,Ser(GalNAc)9,11)-IgA1 Hinge Region Peptide (TFA) (GN5) is a synthetic glycopeptide and can be used for detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients .

HY-153535

THRβ receptor agonist-1	Thyroid Hormone Receptor	Metabolic Disease
THRβ receptor agonist-1 is a THRβ receptor agonist .

HY-174805

THRβ receptor agonist-2	Thyroid Hormone Receptor	Metabolic Disease
THRβ receptor agonist-2 (Example 7-4) is a THRβ receptor agonist. THRβ receptor agonist-2 can be used for research of liver disorder or a cardiometabolic disease .

HY-P1417

TDFA Thr-Asp-F-amidine	Protein Arginine Deiminase	Inflammation/Immunology
TDFA is an irreversible inhibitor of protein arginine deiminase 4 (PAD4).

HY-130718

ThrRS-IN-1	Bacterial	Infection Cancer
ThrRS-IN-1 (Compound 30d) is a threonyl-tRNA synthetase (ThrRS) inhibitor with an IC₅₀ of 1.4 µM and a K_d of 1.36 µM against Salmonella enterica ThrRS (SeThrRS). ThrRS-IN-1 simultaneously targets the tRNA ^Thr and L-threonine binding pockets of ThrRS. ThrRS-IN-1 shows potent antibacterial activities .

HY-P5322

Thrombospondin (TSP-1)-derived CD36 binding motif	Transmembrane Glycoprotein	Cardiovascular Disease Cancer
Thrombospondin (TSP-1)-derived CD36 binding motif is a bioactive hexapeptide. Thrombospondin (TSP-1)-derived CD36 binding motif interferes with the interaction between cells and the extracellular matrix by binding to CD36 and angiostatin, thereby affecting the cell adhesion and migration process. Thrombospondin (TSP-1)-derived CD36 binding motif inhibits platelet aggregation. Thrombospondin (TSP-1)-derived CD36 binding motif exerts an anti-tumor effect against colon cancer .

HY-P11048

Thrombin-cleavable peptide	Thrombin	Cardiovascular Disease Neurological Disease
Thrombin-cleavable peptide is a type of peptide that can be recognized and cleaved by thrombin. After cleavage, Thrombin-cleavable peptide releases thrombolytic peptides to initiate thrombolysis. Thrombin-cleavable peptide can be used in the research of diseases such as ischemic stroke .

HY-P10640

*[Sar1,Thr8]-Angiotensin II*	Angiotensin Receptor	Cardiovascular Disease
[Sar1,Thr8]-Angiotensin II is a potent angiotensin II antagonist. [Sar1,Thr8]-Angiotensin II does not alter cardiac performance. [Sar1,Thr8]-Angiotensin II might be safe for patients with cardiac disease .

HY-W008086A

*(Rac)-H-Thr-OMe hydrochloride*	Amino Acid Derivatives	Others
(Rac)-H-Thr-OMe hydrochloride is the isomer of H-Thr-OMe hydrochloride (HY-W008086), and can be used as an experimental control. H-Thr-OMe.HCl is a threonine derivative .

HY-P2673

*Lys-Arg-Thr-Leu-Arg-Arg* KRTLRR	EGFR	Others
Lys-Arg-Thr-Leu-Arg-Arg (KRTLRR) is a hexapeptide. Lys-Arg-Thr-Leu-Arg-Arg is a substrate of protein kinase C from EGF receptor. Lys-Arg-Thr-Leu-Arg-Arg can be used to determine the activity of protein kinase C .

HY-W130844

*Fmoc-Thr(tBu)-Thr(Psi(Me, Me)Pro)-OH*	Biochemical Assay Reagents	Others
Fmoc-Thr(tBu)-Thr(Psi(Me, Me)Pro)-OH is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W008696

*Fmoc-Thr-OH*	Amino Acid Derivatives	Others
Fmoc-Thr-OH is a threonine derivative .

HY-W005883

*H-Thr-Obzl.HCl*	Amino Acid Derivatives	Others
H-Thr-Obzl.HCl is a threonine derivative .

HY-W008086

*H-Thr-OMe hydrochloride*	Amino Acid Derivatives	Others
H-Thr-OMe.HCl is a threonine derivative .

HY-W008297

*Z-Thr-OMe*	Amino Acid Derivatives	Others
Z-Thr-OMe is a threonine derivative .

HY-W012437

*Boc-Thr-OH*	Amino Acid Derivatives	Others
Boc-Thr-OH is a threonine derivative .

HY-P2673A

*Lys-Arg-Thr-Leu-Arg-Arg acetate* KRTLRR acetate	Fluorescent Dye EGFR	Cancer
Lys-Arg-Thr-Leu-Arg-Arg (KRTLRR) acetate is a hexapeptide. Lys-Arg-Thr-Leu-Arg-Arg acetate is a substrate of EGF receptor protein kinase C and can be used to measure protein kinase C activity .

HY-W007706S1

*Fmoc-Thr(tBu)-OH-15N*	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-Thr(tBu)-OH- ¹⁵N is the ¹⁵N-labeled Fmoc-Thr(tBu)-OH (HY-W007706). Fmoc-Thr(tBu)-OH is a threonine derivative .

HY-W048671

*Fmoc-Thr(TBDMS)-OH*	Amino Acid Derivatives	Others
Fmoc-Thr(TBDMS)-OH is a Threonine derivative. Fmoc-Thr(TBDMS)-OH can be used for the preparation of sugar ligand-tethered functional nucleic acid conjugates for targeted research .

HY-125083

Lys-D-Pro-Thr	Interleukin Related	Metabolic Disease
Lys-D-Pro-Thr, an IL-1beta analogue (Positions 193-195), is a potent IL-1 inhibitor .

HY-W013198

*Z-Thr(Bzl)-OH*	Amino Acid Derivatives	Others
Z-Thr(Bzl)-OH is a threonine derivative .

HY-W008464

*H-Thr(Me)-OH*	Amino Acid Derivatives	Others
H-Thr(Me)-OH is a threonine derivative .

HY-W042013

*H-Thr(tBu)-OMe.HCl*	Amino Acid Derivatives	Others
H-Thr(tBu)-OMe.HCl is a threonine derivative .

HY-22296

*Fmoc-Thr-OBu-t*	Amino Acid Derivatives	Others
Fmoc-Thr-OBu-t is a threonine derivative .

HY-W008800

*Boc-D-Thr-OH*	Amino Acid Derivatives	Others
Boc-D-Thr-OH is a threonine derivative .

HY-W007706

*Fmoc-Thr(tBu)-OH*	Amino Acid Derivatives	Others
Fmoc-Thr(tBu)-OH is a threonine derivative .

HY-W011892

*Z-D-Thr-OH*	Amino Acid Derivatives	Others
Z-D-Thr-OH is a threonine derivative .

HY-W011606

*Boc-Thr(tBu)-OH*	Amino Acid Derivatives	Others
Boc-Thr(tBu)-OH is a threonine derivative .

HY-W018650

*Boc-Thr(Me)-OH*	Amino Acid Derivatives	Others
Boc-Thr(Me)-OH is a threonine derivative .

HY-W016731

*H-Thr(tBu)-OH*	Amino Acid Derivatives	Others
H-Thr(tBu)-OH is a threonine derivative .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-W008315

L-Allothreonine H-allo-Thr-OH	Human Gut Microbiota Metabolites Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
L-Allothreonine (H-allo-Thr-OH) is an endogenous metabolite.

HY-W008315R

L-Allothreonine (Standard) H-allo-Thr-OH (Standard)	Human Gut Microbiota Metabolites Microorganisms Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Reference Standards Endogenous Metabolite
L-Allothreonine (Standard) is the analytical standard of L-Allothreonine. This product is intended for research and analytical applications. L-Allothreonine (H-allo-Thr-OH) is an endogenous metabolite.

HY-W012874

D-Threonine H-D-Thr-OH	Natural Products Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite Drug Intermediate
D-Threonine (H-D-Thr-OH) is one of the important unnatural amino acids used as chiral building blocks in pharmaceutical drugs. D-Threonine is a metabolite of Saccharomyces cerevisiae. D-Threonine is cleaved into glycine and acetaldehyde by the catalytic action of D-threonine aldolase .

HY-126477

NNK 2 Publications Verification	Alkaloids Classification of Application Fields Source classification Pyridine Alkaloids Endogenous metabolite Disease Research Fields Cancer	Endogenous Metabolite
NNK is a nicotine-nitrosated derivative. NNK simultaneously stimulates Bcl2 phosphorylation exclusively at Ser ⁷⁰ and c-Myc at Thr ⁵⁸ and Ser ⁶² through activation of both ERK1/2 and PKCα . NNK induces survival and proliferation of human lung cancer cells. NNK can be used for lung cancer mice model structure .

HY-P0263

Dermaseptin	Infection Natural Products Classification of Application Fields Animals Source classification Disease Research Fields	Bacterial Fungal Antibiotic
Dermaseptin, a peptide isolated from frog skin, exhibits potent antimicrobial activity against bacteria, fungi, and protozoa at micromolar concentration .

HY-P0285

Rabies Virus Glycoprotein 1 Publications Verification	Infection Natural Products Microorganisms Classification of Application Fields Source classification Disease Research Fields	RABV
Rabies Virus Glycoprotein is a 29-amino-acid cell penetrating peptide derived from a rabies virus glycoprotein that can cross the blood-brain barrier (BBB) and enter brain cells.

HY-126477R

NNK (Standard)	Alkaloids Source classification Pyridine Alkaloids Endogenous metabolite	Reference Standards Endogenous Metabolite
NNK (Standard) is the analytical standard of NNK. This product is intended for research and analytical applications. NNK is a nicotine-nitrosated derivative. NNK simultaneously stimulates Bcl2 phosphorylation exclusively at Ser70 and c-Myc at Thr58 and Ser62 through activation of both ERK1/2 and PKCα . NNK induces survival and proliferation of human lung cancer cells. NNK can be used for lung cancer mice model structure .

HY-P1346

APETx2	Natural Products Animals Source classification	Sodium Channel
APETx2, a sea anemone peptide from Anthopleura elegantissima, is a selective and reversible ASIC3 inhibitor, with an IC₅₀ of 63 nM. APETx2 directly inhibits the ASIC3 channel by acting at its external side. APETx2 could reverses acid‐induced and inflammatory pain .

HY-P5672

Maximin 39	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 39 is an antimicrobial peptide derived from the toad brain. Maximin 39 is active against Staphylococcus aureus and Escherichia coli, with MIC values of 18.8, 37.5 μg/mL, respectively .

HY-P5668

Maximin 28	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 28 is an antimicrobial peptide derived from the toad brain. Maximin 28 is active against Staphylococcus aureus, Escherichia coli and Bacillus subtilis, with MIC values of 4.7, 9.4, 75 μg/mL, respectively .

HY-P1841

Glucagon-Like Peptide (GLP) II, human	Natural Products Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite Apoptosis
Glucagon-Like Peptide (GLP) II, human is a 33-amino acid peptide derived from the C-terminal of proglucagon and mainly produced by the intestinal L cells. Glucagon-Like Peptide (GLP) II, human stimulates intestinal mucosal growth and decreases apoptosis of enterocytes .

HY-P1189

Echistatin	Natural Products Animals Classification of Application Fields Source classification Inflammation/Immunology Disease Research Fields	Integrin
Echistatin, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of α_IIbβ₃, α_vβ₃ and α₅β₁ .

HY-P1189A

Echistatin TFA	Natural Products Animals Classification of Application Fields Source classification Metabolic Disease Inflammation/Immunology Disease Research Fields	Integrin
Echistatin TFA, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of α_IIbβ₃, α_vβ₃ and α₅β₁ .

HY-P3055

Dendrotoxin-I DTX-I	Animals Cyclopeptides Source classification Animal Venoms	Potassium Channel
Dendrotoxin-I (DTX-I) is a potent K ⁺ channels blocker with IC₅₀s of 0.13-50 nM for voltage-gated potassium channel subunits K_V1.1, K_V1.2 and K_V1.6, respectively. Dendrotoxin-I, a neurotoxin, has the potential for cancer research .

HY-P0017

Aprotinin 25+ Cited Publications	Cardiovascular Disease Natural Products Animals Source classification Disease Research Fields	Influenza Virus Ser/Thr Protease
Aprotinin is a bovine pancreatic trypsin inhibitor (BPTI) inhibitor which inhibits trypsin and chymotrypsin with K_is of 0.06 pM and 9 nM, respectively.

HY-A0248A

Polymyxin B1 1 Publications Verification	Infection Microorganisms Classification of Application Fields Antibiotics Source classification Antibacterial Disease Research Disease Research Fields Other Antibiotics	Bacterial
Polymyxin B1 is a potent antimicrobial lipopeptide first derived from Bacilus polymyxa. Polymyxin B1 is the major component in Polymyxin B (HY-A0248). Polymyxin B1 can induce lysis of bacterial cells through interaction with their membranes. Polymyxin B1 has the potential for multidrug-resistant Gram-negative bacterial infections treatment .

HY-P0259

Xenin	Natural Products Source classification Endogenous metabolite	Endogenous Metabolite
Xenin is a 25-amino acid peptide initially isolated from human gastric mucosa. Xenin is a gut hormone that can reduce food intake.

HY-P5689

Maximin 42	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 42 is an antimicrobial peptide. Maximin 42 has antibacterial activity against S. aureus (MIC: 37.5 μg/mL). Maximin 42 has hemolytic activities against human red cells .

HY-P5683

Maximin 45	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 45 is an antimicrobial peptide. Maximin 41 has antibacterial activity against S. aureus, E. coli, B. subtilis (MIC: 4.7, 9.4, 75 μg/mL). Maximin 45 has hemolytic activities against human and rabbit red cells .

HY-P5671

Maximin 32	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 32 is an antimicrobial peptide derived from the toad brain. Maximin 32 is active against Staphylococcus aureus and Escherichia coli, with MIC values of 9.4, 18.8 μg/mL, respectively .

HY-P5666

Maximin 15	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 15 is an antimicrobial peptide derived from the toad brain. Maximin 15 is active against Staphylococcus aureus, Escherichia coli and Bacillus subtilis, with MIC values of 9.4, 18.8, 75 μg/mL, respectively .

HY-P1866A

β-Endorphin, equine TFA	Natural Products Source classification Endogenous metabolite	Opioid Receptor
β-Endorphin, equine TFA is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors. β-Endorphin, equine TFA has analgesic properties .

HY-P1866

β-Endorphin, equine	Natural Products Source classification Endogenous metabolite	Opioid Receptor
β-Endorphin, equine is an endogenous opioid peptide, which binds at high affinity to both μ/δ opioid receptors . Analgesic properties .

HY-P1543

Exendin-3	Natural Products Animals Source classification	GLP Receptor Amylases GCGR
Exendin-3 is a biologically active peptides isolated from venoms of the Gila monster lizards, Heloderma horridurn.

HY-P0173B

Chlorotoxin TFA 2 Publications Verification	Natural Products Classification of Application Fields Animals Source classification Disease Research Fields Cancer	Chloride Channel
Chlorotoxin TFA is a peptide isolated from the venom of the scorpion Leiurus quinquestriatus, acts as a chloride channel blocker . Anti-cancer activity .

HY-P1280

Margatoxin 1 Publications Verification	Natural Products Animals Neurological Disease Source classification Disease Research Fields	Potassium Channel
Margatoxin, an alpha-KTx scorpion toxin, is a high affinity inhibitor of Kv1.3 (K_d=11.7 pM). Margatoxin inhibits the Kv1.2 (K_d=6.4 pM) and Kv1.1 (K_d=4.2 nM). Margatoxin, a 39 amino-acid-long peptide, is isolated from the venom of the scorpion Centruroides margaritatus and widely used in ion channel research .

HY-P0173A

Chlorotoxin 2 Publications Verification	Natural Products Animals Classification of Application Fields Source classification Disease Research Fields Cancer	Chloride Channel
Chlorotoxin is a 36 amino-acid peptide from the venom of the Israeli scorpion Leiurus quinquestriatus with anticancer activity. Chlorotoxin is a chloride channel blocker.

HY-P3065

Calcicludine	Natural Products Animals Source classification	Calcium Channel
Calcicludine is a protein toxin from the venom of the green mamba that inhibits high-voltage-activated calcium channel, especially L-type calcium channel .

HY-P0240

Tuftsin 3 Publications Verification	Natural Products Classification of Application Fields Source classification Endogenous metabolite Inflammation/Immunology Disease Research Fields	Endogenous Metabolite
Tuftsin is a tetrapeptide. Tuftsin is a macrophage/microglial activator.

HY-P0275

Proctolin 1 Publications Verification	Natural Products Monophenols Animals Source classification Phenols	Endogenous Metabolite
Proctolin is an endogenous pentapeptide that acts as an excitatory neuromodulator.

HY-P5702

EP3	Animals Ketones, Aldehydes, Acids Source classification	Bacterial Apoptosis Fungal
EP3 is an antimicrobial peptide. EP3 has antibacterial and antifungal activities. EP3 inhibits E. gallinarum, P. pyocyanea, A. baumanii, K. terrigena with a MIC value of 12.85 μg/mL. EP3 also shows antitumor activity against cancer cells, and induces cell apoptosis .

HY-P6293

Heterophyllin A	Natural Products Pseudostellaria heterophylla (Miq.) Pax Source classification Plants Caryophyllaceae	Cathepsin
Heterophyllin A can be isolated from the aboveground parts of Elaeagnus angustifolia.

HY-P0303

Crustacean cardioactive peptide，free acid	Cardiovascular Disease Natural Products Animals Neurological Disease Classification of Application Fields Source classification Disease Research Fields	G Protein-coupled Receptor Kinase (GRK)
Crustacean cardioactive peptide, free acid is a highly conserved, amidated cyclic nonapeptide, first isolated from the pericardial organs of the shore crab Carcinus maenas, where it has a role in regulating heartbeat; Crustacean cardioactive peptide, free acid also modulates the neuronal activity in other arthropods.

HY-P0304

CEF4	Infection Natural Products Microorganisms Classification of Application Fields Source classification Disease Research Fields	Influenza Virus
CEF4 is a peptide that corresponds to aa 342-351 of the influenza A virus nucleocapsid protein.

HY-P0241

Neuromedin B 1 Publications Verification	Natural Products Animals Source classification Endogenous metabolite	Endogenous Metabolite
Neuromedin B (NMB) is a member of Bombesin (BN)-like peptide family in mammals.

HY-A0190

Caerulein Maximum Cited Publications 114 Publications Verification Ceruletide; Cerulein; FI-6934	Cardiovascular Disease Alkaloids Animals Classification of Application Fields Source classification Disease Research Fields Endocrinology Indole Alkaloids	Cholecystokinin Receptor
Caerulein is a decapeptide and a potent cholecystokinin receptor agonist. Caerulein is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .

HY-P1709

Protactin	Microorganisms Antibiotics Source classification Other Antibiotics	Bacterial
Protactin is a pentapeptide lactone produced by Streptomyces cucumeris strain L703-4 (ATCC 53784) with significant antioxidant properties. Protactin can be converted to actinomycin Zp by ferrocyanide oxidation. Actinomycin Zp exhibits potent antibacterial activity in vitro and has significant antitumor effects against P-388 leukemia in a mouse model .

HY-P0279

Systemin	Natural Products other families Classification of Application Fields Source classification Other Diseases Solanum lycopersicum L. Solanaceae Plants Disease Research Fields	Endogenous Metabolite
Systemin, an 18-amino acid polypeptide, has been isolated from tomato leaves that is a powerful inducer of over 15 defensive genes.

HY-P0324A

Parasin I TFA	Infection Natural Products Classification of Application Fields Animals Source classification Disease Research Fields	Bacterial
Parasin I (TFA) is a 19-amino acid histone H2A-derived peptide isolated from the skin of the catfish, and shows antimicrobial activity .

HY-P0324

Parasin I	Infection Natural Products Classification of Application Fields Animals Source classification Disease Research Fields	Bacterial
Parasin I is a 19-amino acid histone H2A-derived peptide isolated from the skin of the catfish, and shows antimicrobial activity.

HY-P5661

Maximin H7	Animals Ketones, Aldehydes, Acids Source classification	Others
Maximin H7 is an antimicrobial peptide derived from toad Bombina maxima .

HY-B0108

Daptomycin 20+ Cited Publications LY146032	Infection Microorganisms Macrolide Antibiotics Classification of Application Fields Antibiotics Source classification Mammalian Cell Culture Antibacterial Disease Research Disease Research Fields	Bacterial Antibiotic
Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.

HY-P5682

Maximin 41	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 41 is an antimicrobial peptide. Maximin 41 has antibacterial activity against S. aureus (MIC: 75 μg/mL). Maximin 41 has hemolytic activities against human red cells .

HY-P5685

Maximin 49	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 49 is an antimicrobial peptide. Maximin 49 has antibacterial activity against S. aureus (MIC: 18.8 μg/mL). Maximin 49 has hemolytic activities against human and rabbit red cells .

HY-P5621

Maximin 63	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Maximin 63 is an antimicrobial peptide derived from the brain of a toad. Maximin 63 has strong activity against S.aureus (MIC: 18.8 μg/mL) .

HY-P5714

Abaecin	Animals Ketones, Aldehydes, Acids Source classification	Bacterial
Abaecin is an antibacterial response peptide. Abaecin shows specific activity against an Apidaecin-resistant Xanthomonas strain .

HY-105055

Didemnin B	Natural Products Animals Classification of Application Fields Marine natural products Source classification Other marine organisms Disease Research Fields Cancer	Others
Didemnin B is a depsipeptide extracted from the marine tunicate Trididemnin cyanophorum. Didemnin B can be used for the research of cancer .

HY-P1539A

Cecropin A TFA	Anti-inflammation/Immunoregulatory Classification of Application Fields Source classification Antibacterial Disease Research Other Antibiotics Infection Microorganisms Antibiotics Anticancer Inflammation/Immunology Disease Research Fields Cancer	Bacterial Antibiotic
Cecropin A TFA is a linear 37-residue antimicrobial polypeptide isolated from Hyalaphora cecropia pupae. Cecropin A TFA exhibits anti-bacterial, anti-inflammatory and anti-cancer activity .

HY-P0190

Iberiotoxin 1 Publications Verification	Cardiovascular Disease Natural Products Animals Classification of Application Fields Source classification Disease Research Fields	Potassium Channel
Iberiotoxin is a toxin isolated from Buthus tamulus scorpion venom. Iberiotoxin is a selective high conductance high conductance Ca ²⁺-activated K ⁺ channel inhibitor with a K_d of ~1 nM. Iberiotoxin does not block other types of voltage-dependent ion channels .

Cat. No.	Product Name	Chemical Structure

HY-159193S

DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA
DHATS(Leu- ¹³C₆, ¹⁵N)PVTIPSAVST(Gly- ¹³C₂, ¹⁵N)HTTPLPVTDT (TFA) is the ¹³C and ¹⁵N labeled isotope of DHATS-PVTIPSAVST-HTTPLPVTDT (TFA) .

HY-P0090S

Calcitonin-13C6,15N4 (salmon) TFA
Calcitonin- ¹³C₆, ¹⁵N₄ (salmon) (Salmon calcitonin- ¹³C₆, ¹⁵N₄) TFA is ¹³C and ¹⁵N-labeled Calcitonin (salmon) (HY-P0090). Calcitonin (salmon) , a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption .

HY-160266

THR-β agonist 7
THR-β agonist-1 (Example 2) is a *THR-β* agonist, with EC₅₀ values of 52 nM and 1017 nM for THR-β and THR-α, respectively .

HY-W007706S1

*Fmoc-Thr(tBu)-OH-15N*
Fmoc-Thr(tBu)-OH- ¹⁵N is the ¹⁵N-labeled Fmoc-Thr(tBu)-OH (HY-W007706). Fmoc-Thr(tBu)-OH is a threonine derivative .

HY-W007706S

*Fmoc-Thr(tBu)-OH-13C4,15N*
Fmoc-Thr(tBu)-OH- ¹³C₄, ¹⁵N is a ¹⁵N-labeled and ¹³C-labled Fmoc-Thr(tBu)-OH (HY-W007706). Fmoc-Thr(tBu)-OH is a threonine derivative .

HY-W012874S

D-Threonine-d2
D-Threonine-d₂ (H-D-Thr-OH-d₂) is the deuterium labeled D-Threonine (HY-W012874). D-Threonine is one of the important unnatural amino acids used as chiral building blocks in pharmaceutical drugs. D-Threonine is a metabolite of Saccharomyces cerevisiae. D-Threonine is cleaved into glycine and acetaldehyde by the catalytic action of D-threonine aldolase.

HY-172439S

Simedeutirom
Simedeutirom is the agonist for thyroid hormone beta receptor (THRβ) and can be used for researchs of metabolic diseases, such as obesity and diabetes mellitus .

HY-P0058S

Pramlintide-(Ala-13C3,15N)
Pramlintide-(Ala- ¹³C₃, ¹⁵N) is the ¹³C- and ¹⁵N-labeled Pramlintide. Pramlintide is a polypeptide analogue of human amylin. Pramlintide, an antidiabetic agent, is antineoplastic in colorectal cancer .

HY-163992S

VTMTRDTSISTAYMELSR-(Ile-13C6,15N)
VTMTRDTSISTAYMELSR-(Ile-13C6,15N) is the ¹³C and ¹⁵N labeled isotope of VTMTRDTSISTAYMELSR .

HY-P1142S

GLP-2(rat) (Ala-13C3,15N)
GLP-2(rat) (Ala- ¹³C3, ¹⁵N) is ¹³C and ¹⁵N labeled GLP-2(rat) (HY-P1142). GLP-2(rat) is an intestinal growth factor. GLP-2(rat) stimulates cell proliferation and inhibits apoptosis. GLP-2(rat) enhances mucosal mass and function in residual small intestine after massive small bowel resection (MSBR).

HY-P1142S1

GLP-2(rat) (Ala-13C3,15N) TFA
GLP-2(rat) (Ala- ¹³C3, ¹⁵N) TFA is ¹³C and ¹⁵N labeled GLP-2(rat) (HY-P1142). GLP-2(rat) is an intestinal growth factor. GLP-2(rat) stimulates cell proliferation and inhibits apoptosis. GLP-2(rat) enhances mucosal mass and function in residual small intestine after massive small bowel resection (MSBR).

HY-173086S

TPSLPTPPTR-(Arg-13C6,15N4) TFA
TPSLPTPPTR-(Arg- ¹³C₆, ¹⁵N₄) TFA is the ¹³C- and ¹⁵N-labeled TPSLPTPPTR-(Arg) TFA.

HY-163423S

TELAEPTSTR-(Arg-13C6,15N4)
TELAEPTSTR-(Arg- ¹³C₆, ¹⁵N₄) is ¹³C and ¹⁵N labeled TELAEPTSTR-(Arg).

HY-P2625S

GLP-2(3-33) (Leu-13C6,15N)
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-P2625S1

GLP-2(3-33) (Leu-13C6,15N) TFA
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) TFA is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-P3207S

DLPLTFGGGT-Lys-13C6,15N2 TFA
DLPLTFGGGT-Lys-13C6,15N2 (TFA) is a deuterated labeled DLPLTFGGGTK .

HY-156345S1

LPFTFGQGTK-(Lys-13C6,15N2) (TFA)
LPFTFGQGTK-(Lys- ¹³C₆, ¹⁵N₂) TFA is the peptide containing ¹³C- and ¹⁵N-labeled Lys.

HY-173105S

TPEEAHALSA(Pro-13C5,15N)TSR TFA
TPEEAHALSA(Pro- ¹³C₅, ¹⁵N)TSR TFA is the ¹³C- and ¹⁵N-labeled TPEEAHALSA(Pro)TSR TFA.

HY-163427S

FNLEALVTHTLPFEK-(Lys-13C6,15N2)
FNLEALVTHTLPFEK-(Lys- ¹³C₆, ¹⁵N₂) is ¹³C and ¹⁵N labeled FNLEALVTHTLPFEK-(Lys) .

HY-163993S

GMDRWGQGTLVTVSS-(Leu-13C6,15N)
GMDRWGQGTLVTVSS-(Leu-13C6,15N) is the ¹³C and ¹⁵N labeled isotope of GMDRWGQGTLVTVSS .

HY-159192S

SADDNIKTPAE(Arg-13C6,15N4)LLGPLPPSADDNLKT TFA
SADDNIKTPAE(Arg- ¹³C6, ¹⁵N4)LLGPLPPSADDNLKT (TFA) is the ¹³C and ¹⁵N labeled isotope of SADDNIKTPAE-LLGPLPPSADDNLKT (TFA) .

HY-158992S

SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA
SP-(Val- ¹³C₅, ¹⁵)-EKNQ-(Leu- ¹³C₆, ¹⁵)-TIDFINIVKDPVPHNEYKT TFA is a ¹³C- and ¹⁵N-labeled peptide containing ¹³C₅, ¹⁵N-labeled valine (Val) and ¹³C₆, ¹⁵N-labeled leucine (Leu).

HY-P0014AS

Liraglutide-d8 tetraTFA
Liraglutide-d₈ tetraTFA is deuterium labeled Liraglutide (HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .

HY-P0014S2

Liraglutide-13C6,15N TFA
Liraglutide- ¹³C₆, ¹⁵N (TFA)is the ¹³C and ¹⁵N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus .

HY-P0014S1

Liraglutide-13C5,15N TFA
Liraglutide- ¹³C₅, ¹⁵N (tetraTFA) is the ¹³C and ¹⁵N labeled Liraglutide (HY-P0014) . Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus .

HY-114118S3

Semaglutide-13C6,15N TFA

Semaglutide- ¹³C₆, ¹⁵N TFA is the ¹³C- and ¹⁵N-labeled Semaglutide TFA (HY-114118A). Semaglutide TFA is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide TFA promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide TFA also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide TFA has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide TFA can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-13443S

Exendin-4 (Leu-13C6,15N) TFA
Exendin-4 (Leu- ¹³C₆, ¹⁵N) (Exenatide (Leu- ¹³C₆, ¹⁵N)) TFA is the ¹³C- and ¹⁵N-labeled Exendin-4 TFA (HY-13443). Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC₅₀ of 3.22 nM .

HY-114118S1

Semaglutide-d8 tetraTFA

Semaglutide-d₈ tetraTFA is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-114118S

Semaglutide-d8

Semaglutide-d₈ is the deuterium labeled Semaglutide (HY-114118). Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .

HY-P0119S

Lixisenatide (Leu-13C6,15N) TFA

Lixisenatide (Leu- ¹³C₆, ¹⁵N) TFA is the ¹³C- and ¹⁵N-labeled Lixisenatide (HY-P0119). Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Lixisenatide inhibits the inflammatory response through down regulation of pro-inflammatory cytokines, and suppresses of the Akt-MEK1/2 signaling pathway. Lixisenatide can inhibit oxidative stress, mitochondrial dysfunction and apoptosis. Lixisenatide can be used for the researches of inflammation, metabolic disease, neurological disease and cardiovascular disease, such as rheumatoid arthritis, diabetes, Alzheimer's disease and atherosclerosis .

HY-173106S

YTASD(Leu-13C6,15N)FR TFA
YTASD(Leu- ¹³C₆, ¹⁵N)FR TFA is the ¹³C- and ¹⁵N-labeled YTASD(Leu)FR TFA.

HY-173085S

TPPSSGEPPK-(Lys-13C6,15N2) TFA
TPPSSGEPPK-(Lys- ¹³C₆, ¹⁵N₂) TFA is the ¹³C- and ¹⁵N-labeled TPPSSGEPPK-(Lys) TFA.

HY-159064S

DSPSAPVNVT(Val-13C5,15N)R TFA
DSPSAPVNVT(Val- ¹³C₅, ¹⁵)R TFA is the ¹³C and ¹⁵N-labeled DSPSAPVNVT(Val)R. Radioactive isotopes labeled compounds can be used in metabolic analysis, allowing the movement of individual atoms to be precisely tracked and quantified .

HY-P5190S

RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE
RQIK-(Lys-fructosyl)-QTA-(Leu- ¹³C₆, ¹⁵N)-VE is the ¹³C and ¹⁵N labeled compound .

HY-163422S

PHSHPALTPEQK-(Lys-13C6,15N2)
PHSHPALTPEQK-(Lys- ¹³C₆, ¹⁵N₂) is ¹³C and ¹⁵N labeled PHSHPALTPEQK-(Lys).

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

HY-173087S

TPPSSGEPPKSGDR-(Arg-13C6,15N4) TFA
TPPSSGEPPKSGDR-(Arg- ¹³C₆, ¹⁵N₄) TFA is a is the ¹³C- and ¹⁵N-labeled TPPSSGEPPKSGDR-(Arg) TFA.

HY-159046S

ASGITFSNSGMHW(Val-13C5,15N)R TFA
ASGITFSNSGMHW(Val-13C5,15N)R TFA is an isotope of ASGITFSNSGMHWVR TFA labeled with ¹³C and ¹⁵N .

HY-173089S

TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) TFA
TPSLP(pT)PP(pT)REPK-(Lys- ¹³C₆, ¹⁵N₂) TFA is the ¹³C- and ¹⁵N-labeled TPSLP(pT)PP(pT)REPK-(Lys) TFA.

HY-156343S1

SNNYATHYAESVK-(Lys-13C6,15N2) (TFA)
SNNYATHYAESVK-(Lys- ¹³C₆, ¹⁵N₂) (TFA) is the peptide containing ¹³C- and ¹⁵N-labeled Lys.

HY-176176S

MDEKMLVLWVVALS(Gly-13C2,15N)IST
MDEKMLVLWVVALS(Gly- ¹³C₂, ¹⁵N)IST is the ¹³C- and ¹⁵N-labeled MDEKMLVLWVVALSIST.

HY-156341S1

LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA)
LLIYYTSSLHSGVPSR-(Arg- ¹³C₆, ¹⁵N₄) (TFA) is the peptide containing ¹³C- and ¹⁵N-labeled Arg.

HY-159191S

VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA
VQPGQN(Phe- ¹³C9, ¹⁵N)HMFTKEKLEEVIKDI (TFA) is the ¹³C and ¹⁵N labeled isotope of VQPGQN-HMFTKEKLEEVIKDI (TFA) .

HY-176177S

DEKM(Leu-13C6,15N)VLWVVALSGISTLFFAA
DEKM(Leu- ¹³C₆, ¹⁵N)VLWVVALSGISTLFFAA is the ¹³C- and ¹⁵N-labeled DEKMVLWVVALSGISTLFFAA.

HY-P10324

TAT-p16
TAT-p16 (p16INK4a peptide) is a peptide mimic of p16INK4a that can induce an early G phase cell cycle arrest in the absence of active cyclin E:Cdk2 complex .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks